Bioenergetics and metabolism: a bench to bedside perspective

被引:25
|
作者
Swerdlow, Russell H. [1 ,2 ,3 ,4 ]
机构
[1] Univ Kansas, Alzheimers Dis Ctr, Kansas City, KS USA
[2] Univ Kansas, Med Ctr, Dept Neurol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA
[3] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA
[4] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA
关键词
Alzheimer's disease; bioenergetics; metabolism; mitochondria; neurodegeneration; AMYLOID PRECURSOR PROTEIN; MITOCHONDRIAL CASCADE HYPOTHESIS; COMPLEX-I DEFICIENCY; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; PARKINSONS-DISEASE; CREATINE SUPPLEMENTATION; CYTOCHROME-OXIDASE; ENERGY-METABOLISM; SKELETAL-MUSCLE;
D O I
10.1111/jnc.13509
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabolism' refers to the vast collection of chemical processes that occur within a living organism. Within this broad designation, one can identify metabolism events that relate specifically to energy homeostasis, whether they occur at the subcellular, cellular, organ, or whole organism level. This review operationally refers to this type of metabolism as energy metabolism' or bioenergetics.' Changes in energy metabolism/bioenergetics have been linked to brain aging and a number of neurodegenerative diseases, and research suggests mitochondria may uniquely contribute to this. Interventions that manipulate energy metabolism/bioenergetic function and mitochondria may have therapeutic potential and efforts intended to accomplish this are playing out at basic, translational, and clinical levels. This review follows evolving views of energy metabolism's role in neurodegenerative diseases but especially Alzheimer's disease, with an emphasis on the bench-to-bedside process whose ultimate goal is to develop therapeutic interventions. It further considers challenges encountered during this process, which include linking basic concepts to a medical question at the initial research stage, adapting conceptual knowledge gained to a disease-associated application in the translational stage, extending what has been learned to the clinical arena, and maintaining support for the research at each of these fundamentally linked but functionally distinct stages.
引用
收藏
页码:126 / 135
页数:10
相关论文
共 50 条
  • [1] Metabolism: from bench to bedside
    Gary S Firestein
    Nature Medicine, 2010, 16 : 387 - 387
  • [2] Metabolism: from bench to bedside INTRODUCTION
    Firestein, Gary S.
    Lopez, Juan Carlos
    NATURE MEDICINE, 2010, 16 (04) : 387 - 387
  • [3] Iron Metabolism: Bedside to Bench and Back
    Means, Robert T.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2013, 346 (05): : 402 - 402
  • [4] Bench-to-bedside review: Metabolism and nutrition
    Michaël P Casaer
    Dieter Mesotten
    Miet RC Schetz
    Critical Care, 12
  • [5] Metformin and Cancer Glucose Metabolism: At the Bench or at the Bedside?
    Marini, Cecilia
    Cossu, Vanessa
    Bauckneht, Matteo
    Lanfranchi, Francesco
    Raffa, Stefano
    Orengo, Anna Maria
    Ravera, Silvia
    Bruno, Silvia
    Sambuceti, Gianmario
    BIOMOLECULES, 2021, 11 (08)
  • [6] Bench-to-bedside review: Metabolism and nutrition
    Casaer, Michael P.
    Mesotten, Dieter
    Schetz, Miet R. C.
    CRITICAL CARE, 2008, 12 (04):
  • [7] Bench to bedside and bedside to bench: Where are we?
    Adams, AJ
    OPTOMETRY AND VISION SCIENCE, 2006, 83 (03) : 125 - 126
  • [8] A perspective of pemphigus from bedside and laboratory-bench
    Kitajima, Yasuo
    Aoyama, Yumi
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2007, 33 (1-2) : 57 - 66
  • [9] Metabolism of asymmetric dimethylarginine in hypoxia: from bench to bedside
    Hannemann, Juliane
    Zummack, Julia
    Hillig, Jonas
    Boeger, Rainer
    PULMONARY CIRCULATION, 2020, 10 (1_SUPPL) : 31 - 41
  • [10] BIOMARKERS FROM BENCH TO BEDSIDE: PHARMACEUTICAL INDUSTRY PERSPECTIVE
    Troha, Janice
    Shoemaker, Steve
    Scoggin, Charles
    Gabriel, Sherif
    PEDIATRIC PULMONOLOGY, 2013, 48 : 112 - 113